Erudio Healtherudio.com
Hematology congress
19th International Conference on Malignant Lymphoma 2027
Jun 15–19, 2027 · Lugano, Switzerland
Starts in 216 days
- Today · Nov 11
- Jun 15–19Meeting
- Jun 26First reports likely
- Dates
- Jun 15–19, 2027Central European Time (Lugano)
- Website
- reg.icml.ch ↗
- Organiser
- Foundation for the Institute of Oncology Research (IOR), with AACR
- Calendar
- Add to calendar
Trials at ICML 2027
No trial is placed here yet.
A trial is listed only when at least two public sources, from two different publishers, place its results or presentation at 19th International Conference on Malignant Lymphoma 2027; each row says how many did.
What happens next
- Jun 15–19: the meeting; the list fills as clinicians talk about it.
- After: reports on the trials discussed, every statement linked to its source.
Hematology reports so far
The newest published reports on hematology trials from other congresses.
- IMS 2026EXCALIBER-RRMMiberdomide plus daratumumab · relapsed or refractory multiple myeloma490 statements · 105 sources
- IMS 2026MELT-MMmezigdomide plus elranatamab plus dexamethasone · relapsed/refractory multiple myeloma54 statements · 13 sources
- EHA 2026LINKER-AL2linvoseltamab · relapsed or refractory systemic light chain amyloidosis149 statements · 25 sources
Editions
| Edition | Dates | City |
|---|---|---|
| ICML 2027this page | Jun 15–19, 2027 | Lugano |
| ICML 2025 | Jun 17–21, 2025 | Lugano |
| ICML 2023 | Jun 13–17, 2023 | Lugano |
| ICML 2021 | Jun 18–22, 2021 | Virtual |
| ICML 2019 | Jun 18–22, 2019 | Lugano |
Next on the calendar
| Congress | Dates | City |
|---|---|---|
| ESMO GI 2027 | Jun 30 – Jul 3 | Barcelona |
| SOHO 2027 | Aug 25–28 | Houston |
| WCLC 2027 | Sep 11–14 | Denver |
How a trial gets on this page
A trial is listed only when at least two public sources, from two different publishers, place its results or presentation at 19th International Conference on Malignant Lymphoma 2027; each row says how many did. The list is rebuilt every six hours.Reports
Focused$750Standard$1,250Deep$1,950Pricing
Priced by size, licensed permanently for your organization's internal use, with MCP access for your AI agent. Organised by Foundation for the Institute of Oncology Research (IOR), with AACR; Erudio is not affiliated with it.